Local gene transfer of tissue factor pathway inhibitor regulates intimal hyperplasia in atherosclerotic arteries
-
- Pierre Zoldhelyi
- Wafic Said Molecular Cardiology and Gene Therapy Research Laboratory, Texas Heart Institute, Houston, TX 77030; and Department of Medicine (Cardiology), The University of Texas–Houston Medical School, Houston, TX 77030
-
- Zhi-Qiang Chen
- Wafic Said Molecular Cardiology and Gene Therapy Research Laboratory, Texas Heart Institute, Houston, TX 77030; and Department of Medicine (Cardiology), The University of Texas–Houston Medical School, Houston, TX 77030
-
- Harnath S. Shelat
- Wafic Said Molecular Cardiology and Gene Therapy Research Laboratory, Texas Heart Institute, Houston, TX 77030; and Department of Medicine (Cardiology), The University of Texas–Houston Medical School, Houston, TX 77030
-
- Janice M. McNatt
- Wafic Said Molecular Cardiology and Gene Therapy Research Laboratory, Texas Heart Institute, Houston, TX 77030; and Department of Medicine (Cardiology), The University of Texas–Houston Medical School, Houston, TX 77030
-
- James T. Willerson
- Wafic Said Molecular Cardiology and Gene Therapy Research Laboratory, Texas Heart Institute, Houston, TX 77030; and Department of Medicine (Cardiology), The University of Texas–Houston Medical School, Houston, TX 77030
抄録
<jats:p> Tissue factor (TF), the initiator of blood coagulation and thrombosis, is up-regulated after vascular injury and in atherosclerotic states. Systemic administration of recombinant TF pathway inhibitor (TFPI) has been reported to decrease intimal hyperplasia after vascular injury and also to suppress systemic mechanisms of blood coagulation and thrombosis. Here we report that, in heritable hyperlipidemic Watanabe rabbits, adenoviral gene transfer of TFPI to balloon-injured atherosclerotic arteries reduced the extent of intimal hyperplasia by 43% ( <jats:italic>P</jats:italic> < 0.05) compared with a control vector used at identical titer (1 × 10 <jats:sup>10</jats:sup> plaque-forming units/ml). Platelet aggregation and coagulation studies performed 7 days after local gene transfer of TFPI failed to show any impairment in systemic hemostasis. At time of sacrifice, 4 weeks after vascular injury, the 10 <jats:italic>Ad-TFPI</jats:italic> treated carotid arteries were free of thrombi, whereas two control-treated arteries were occluded ( <jats:italic>P</jats:italic> , not significant). These findings suggest that TFPI overexpressed in atherosclerotic arteries can regulate hyperplastic response to injury in the absence of changes in the hemostatic system, establishing a role for local TF regulation as target for gene transfer-based antirestenosis therapies. </jats:p>
収録刊行物
-
- Proceedings of the National Academy of Sciences
-
Proceedings of the National Academy of Sciences 98 (7), 4078-4083, 2001-03-27
Proceedings of the National Academy of Sciences
- Tweet
キーワード
詳細情報 詳細情報について
-
- CRID
- 1363670319575941888
-
- NII論文ID
- 80012339142
-
- ISSN
- 10916490
- 00278424
-
- データソース種別
-
- Crossref
- CiNii Articles